We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$332B
$116M 0.67%
317,480
-55,209
-15% -$20M
MCK icon
27
McKesson
MCK
$98.5B
$110M 0.64%
150,600
+29,197
+24% +$20.6M
MU icon
28
Micron Technology
MU
$1.04T
$108M 0.62%
875,156
-231,085
-21% -$21.6M
ABBV icon
29
AbbVie
ABBV
$458B
$107M 0.62%
575,792
+174,294
+43% +$32.4M
AXP icon
30
American Express
AXP
$223B
$101M 0.58%
315,729
-5,513
-2% -$1.55M
LRCX icon
31
Lam Research
LRCX
$382B
$100M 0.58%
1,030,267
+196,434
+24% +$15.6M
WAB icon
32
Wabtec
WAB
$51.1B
$97.4M 0.56%
465,026
+32,050
+7% +$6.16M
NFLX icon
33
Netflix
NFLX
$292B
$96.8M 0.56%
723,050
+186,010
+35% +$21M
ADSK icon
34
Autodesk
ADSK
$44.3B
$95.3M 0.55%
307,776
-26,883
-8% -$7.63M
ZTS icon
35
Zoetis
ZTS
$31.6B
$92.8M 0.53%
594,840
+96,079
+19% +$15.2M
MELI icon
36
Mercado Libre
MELI
$91.3B
$92.3M 0.53%
35,312
-2,259
-6% -$5.28M
ON icon
37
ON Semiconductor
ON
$33.8B
$90.3M 0.52%
1,722,891
-31,703
-2% -$1.38M
BSX icon
38
Boston Scientific
BSX
$65.8B
$89.8M 0.52%
836,025
+421,213
+102% +$42.6M
DHR icon
39
Danaher
DHR
$135B
$89.3M 0.51%
451,933
+52,609
+13% +$10.2M
CSCO icon
40
Cisco
CSCO
$450B
$88.9M 0.51%
1,280,687
+210,899
+20% +$13M
PGR icon
41
Progressive
PGR
$124B
$87.8M 0.51%
328,955
-4,063
-1% -$1.11M
BKNG icon
42
Booking.com
BKNG
$138B
$85.4M 0.49%
368,950
-2,975
-0.8% -$609K
ICE icon
43
Intercontinental Exchange
ICE
$82.4B
$84.7M 0.49%
461,821
+110,734
+32% +$19M
ECL icon
44
Ecolab
ECL
$75.6B
$81.9M 0.47%
303,773
-6,191
-2% -$1.57M
TSLA icon
45
Tesla
TSLA
$1.24T
$79.1M 0.46%
248,894
-267,095
-52% -$80.5M
VRTX icon
46
Vertex Pharmaceuticals
VRTX
$121B
$78.5M 0.45%
176,398
-21,889
-11% -$10.1M
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$36.3B
$77.6M 0.45%
238,084
-11,835
-5% -$3.27M
TJX icon
48
TJX Companies
TJX
$170B
$76.9M 0.44%
622,302
-20,659
-3% -$2.62M
GEV icon
49
GE Vernova
GEV
$270B
$76M 0.44%
143,660
+56,203
+64% +$23.4M
MRVL icon
50
Marvell Technology
MRVL
$174B
$75.3M 0.43%
972,751
+107,344
+12% +$6.7M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.